Related Experiment Video
Updated: Jul 1, 2026
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Application of OpenArray Technology to Assess Changes in the Expression of Functionally Significant Genes in the
Dmitry Troshev1, Anna Kolacheva1, Ekaterina Pavlova1
1Laboratory of Neural and Neuroendocrine Regulations, Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, 119334 Moscow, Russia.
Abstract:
Studying the molecular mechanisms of the pathogenesis of Parkinson's disease (PD) is critical to improve PD treatment. We used OpenArray technology to assess gene expression in the substantia nigra (SN) cells of mice in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD and in controls. Among the 11 housekeeping genes tested, Rps27a was taken as the reference gene due to its most stable expression in normal and experimental conditions. From 101 genes encoding functionally significant proteins of nigrostriatal dopaminergic neurons, 57 highly expressed genes were selected to assess their expressions in the PD model and in the controls. The expressions of Th, Ddc, Maoa, Comt, Slc6a3, Slc18a2, Drd2, and Nr4a2 decreased in the experiment compared to the control, indicating decreases in the synthesis, degradation, and transport of dopamine and the impaired autoregulation of dopaminergic neurons. The expressions of Tubb3, Map2, Syn1, Syt1, Rab7, Sod1, Cib1, Gpx1, Psmd4, Ubb, Usp47, and Ctsb genes were also decreased in the MPTP-treated mice, indicating impairments of axonal and vesicular transport and abnormal functioning of the antioxidant and ubiquitin-proteasome systems in the SN. The detected decreases in the expressions of Snca, Nsf, Dnm1l, and Keap1 may serve to reduce pathological protein aggregation, increase dopamine release in the striatum, prevent mitophagy, and restore the redox status of SN cells.
Insights
This study reveals how Parkinson's disease (PD) affects gene expression in mouse substantia nigra cells. Key genes involved in dopamine function, transport, and cellular maintenance show significant changes, offering insights into PD pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Parkinson's disease (PD) pathogenesis involves complex molecular mechanisms in the substantia nigra (SN).
- Understanding gene expression changes is crucial for developing effective PD treatments.
Purpose of the Study:
- To investigate gene expression profiles in the SN of mice using a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD.
- To identify specific genes and pathways affected by MPTP-induced neurodegeneration.
Main Methods:
- Gene expression analysis using OpenArray technology in SN cells from MPTP-treated mice and controls.
- Selection of 57 highly expressed genes encoding functionally significant proteins of nigrostriatal dopaminergic neurons.
- Identification of Rps27a as a stable reference gene for normalization.
Main Results:
- Decreased expression of genes involved in dopamine synthesis, degradation, transport (e.g., Th, Ddc, Slc6a3), and autoregulation (e.g., Drd2, Nr4a2).
- Reduced expression of genes related to axonal/vesicular transport (e.g., Tubb3, Syn1), antioxidant systems (e.g., Sod1), and ubiquitin-proteasome system (e.g., Ubb).
- Observed decreases in Snca, Nsf, Dnm1l, and Keap1 suggest potential protective mechanisms against protein aggregation and redox imbalance.
Conclusions:
- MPTP-induced PD in mice leads to widespread alterations in gene expression within the SN.
- These changes impact critical dopaminergic functions, cellular transport, and protective systems.
- The study provides molecular insights into PD pathogenesis and identifies potential therapeutic targets.
More Related Videos
06:09Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
